Skip to content
10-Q

Quarterly Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-22-033764

← back to feed
Filed
Jun 21, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jun 16, 2022 179.98M sh
Current Liabilities Q2 2022 · Mar 31, 2022 $2.17M
Current Liabilities Q2 2022 · Sep 30, 2021 $2.8M
Total Assets Q2 2022 · Mar 31, 2022 $35.7K
Total Assets Q2 2022 · Sep 30, 2021 $44.58K
Shares Diluted Q2 2022 · Mar 31, 2021 68.91M sh
Shares Diluted Q2 2022 · Mar 31, 2021 68.91M sh
Operating Cash Flow Q2 2022 · Mar 31, 2021 −$172.04K
Stockholders Equity Q2 2022 · Mar 31, 2021 −$2.8M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$2.83M
Stockholders Equity Q2 2022 · Sep 30, 2020 −$2.67M
Eps Diluted Q2 2022 · Mar 31, 2021 $0.00
Eps Diluted Q2 2022 · Mar 31, 2021 −$0.01
Eps Basic Q2 2022 · Mar 31, 2021 $0.00
Eps Basic Q2 2022 · Mar 31, 2021 −$0.01
Sga Expense restated Q2 2022 · Mar 31, 2021 $77.56K
Sga Expense Q2 2022 · Mar 31, 2021 $203.82K
Rd Expense Q2 2022 · Mar 31, 2021 $16.07K
Rd Expense Q2 2022 · Mar 31, 2021 $44.74K
Net Income restated Q2 2022 · Mar 31, 2021 −$266.36K
Net Income Q2 2022 · Mar 31, 2021 −$438.22K
Operating Income restated Q2 2022 · Mar 31, 2021 −$93.62K
Operating Income Q2 2022 · Mar 31, 2021 −$248.56K